Cited by 717Adrenal and Paraganglionic TumorsAdrenal Hormones and DisordersNeuroendocrine Tumor Research Advances

The DOI matches its Crossref record; 64 of the 67 references it cites were found in a registry or an index.

Clinical Features of Adrenocortical Carcinoma, Prognostic Factors, and the Effect of Mitotane Therapy

Open access

Abstract

Adrenocortical carcinoma is a rare tumor, and only limited information is available about its natural history and the effects of therapy. We studied 105 patients (75 female and 30 male; mean age, 46 years) with adrenocortical carcinoma who were referred to us between 1963 and 1987. The average duration of symptoms before diagnosis was 8.7 months. At the time of diagnosis, 68 percent of the patients had endocrine symptoms, and 30 percent had distant metastases. Hormonal studies showed that 79 percent of the tumors were functional. Eighty patients underwent surgery, and 59 also received the adrenal cytotoxic agent mitotane. The median disease-free interval after surgery was 12.1 months (range, 1 to 175). Tumor dissemination occurred in 82 percent of the patients, most commonly to the lung, liver, and adjacent organs. The median survival time was 14.5 months (range, less than 1 to 175), and the five-year survival was 22 percent. Age over 40 years and the presence of metastases at the time of diagnosis were the only factors recognized as indicating a poor prognosis. Mitotane controlled hormonal secretion in 75 percent of the patients. Eight mitotane-treated patients had partial tumor regression, but the drug did not have a significant effect on survival. We conclude that adrenocortical carcinoma carries a poor prognosis. Mitotane therapy may offer transient benefits, particularly in controlling endocrine symptoms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199004263221705

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Research works printed but not linked: 21

  1. Plager, 1984, Int Adv Surg Oncol, 7, 329
  2. Macfarlane, 1958, Ann R Coll Surg Engl, 23, 155
  3. Heinbecker, 1957, Surg Gynecol Obstet, 105, 21
  4. Brennan, 1987, CA, 37, 348
  5. Bradley, 1975, Surg Gynecol Obstet, 141, 507
  6. Greenberg, 1978, Am Surg, 44, 81
  7. Ostuni, 1975, Arch Intern Med, 135, 1257, 10.1001/archinte.1975.00330090129015 · DOI
  8. Haq, 1980, Cancer Treat Rep, 64, 909
  9. Bricaire, 1977, Nouv Presse Med, 6, 3650
  10. Rappaport, 1978, Arch Fr Pediatr, 35, 551
  11. Levine, 1978, Am J Dis Child, 132, 238
  12. Lejonc, 1978, Nouv Presse Med, 7, 3147
  13. Pugeat, 1980, Ann Endocrinol, 41, 107
  14. Cathelineau, 1980, Ann Endocrinol, 41, 65
  15. Cassan, 1978, Nouv Presse Med, 7, 2153
  16. Benaily, 1975, Arch Fr Pediatr, 32, 441
  17. Cariou, 1982, Nouv Presse Med, 11, 2821
  18. Charbonnel, 1980, Nouv Presse Med, 9, 239
  19. Jarabak, 1981, JAMA, 246, 1706, 10.1001/jama.1981.03320150054033 · DOI
  20. Levy, 1985, Ann Pediatr (Paris), 32, 541
  21. du Rostu, 1987, Presse Med, 16, 951

Cited by

Sorted by citations

Items 501–600 of 712

Metadata

Authors
Luton, J.-P., Cerdas, S., Billaud, L., Thomas, G., Guilhaume, B., Bertagna, X., Laudat, M.-H., Louvel, A., Chapuis, Y., Blondeau, P., Bonnin, A., & Bricaire, H.
Affiliations
Hôpital Cochin (FR)
Venue
New England Journal of Medicine
Published
1990-04-26
Volume
322
Issue
17
Pages
1195-1201
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2336089418
Cited by
717
References
67
Citations by year
2026: 8 · 2025: 8 · 2024: 15 · 2023: 26 · 2022: 22 · 2021: 31 · 2020: 20 · 2019: 17 · 2018: 23 · 2017: 16 · 2016: 19 · 2015: 27 · 2014: 25 · 2013: 19 · 2012: 31
FWCI
12.17
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
Keywords
adrenocortical carcinoma, mitotane, prognostic factors, adrenal surgery, metastasis, survival, endocrine symptoms, tumor regression, adrenocortical function, age over 40
MeSH terms
Adrenal Cortex Hormones, Adrenal Cortex Neoplasms, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mitotane, Neoplasm Metastasis, Prognosis, Retrospective Studies, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review